Atlas Trials

Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals

Clinical trial NCT02616874 · COMPLETED

Trial details

NCT number
NCT02616874
Sponsor
IrsiCaixa
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV
Start date
2016-02-01
Primary completion
2016-09-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.